Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort Study. (2021)
Attributed to:
MICA: Treatment According to Response in Giant cEll arTeritis (TARGET)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/art.41728
PubMed Identifier: 33750043
Publication URI: http://europepmc.org/abstract/MED/33750043
Type: Journal Article/Review
Volume: 73
Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)
Issue: 9
ISSN: 2326-5191